基本信息 产品详情 公司简介 推荐产品
网站主页 PARK7 Rabbit Polyclonal Antibody PARK7兔多抗
  • PARK7 Rabbit Polyclonal Antibody | 兔多抗 | EnkiLife恩玑生命

PARK7 Rabbit Polyclonal Antibody | 兔多抗 | EnkiLife恩玑生命

PARK7 Rabbit Polyclonal Antibody
询价 1支 起订
湖北 更新日期:2025-10-20

武汉恩玑生命科技有限公司

VIP1年
联系人:吴经理
手机:18755910559 拨打
邮箱:order@enkilife.cn

产品详情:

中文名称:
PARK7兔多抗
英文名称:
PARK7 Rabbit Polyclonal Antibody
品牌:
EnkiLife
产地:
中国
保存条件:
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
产品类别:
抗体
是否进口:
用途:
科研

产品概述

产品名称(Product Name)

PARK7 Rabbit Polyclonal Antibody

描述(Description)

Rabbit Polyclonal Antibody

宿主(Host)

Rabbit

应用(Application)

WB,IHC-P,IF-P,IF-F,ICC/IF,ELISA

种属反应性(Reactivity)

Human,Mouse

 

产品性能

偶联物(Conjugation)

Unconjugated

修饰(Modification)

Unmodified

同种型(Isotype)

IgG

克隆(Clonality)

Polyclonal

形式(Form)

Liquid

存放说明(Storage)

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

储存溶液(Buffer)

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% New type preservative N.

纯化方式(Purification)

Affinity purification

 

免疫原

基因名(Gene Name)

PARK7

别名(Alternative Names)

PARK7; Protein DJ-1; Oncogene DJ1; Parkinson disease protein 7

基因ID(Gene ID)

11315

蛋白ID(SwissProt ID)

Q99497

 

产品应用

稀释比(Dilution Ratio)

WB 1:500-1:2000, IHC-P 1:100-1:300, IF-P/IF-F/ICC/IF 1:200-1:1000, ELISA 1:10000.Not yet tested in other applications.

蛋白分子量(Molecular Weight)

22kDa

 

研究背景

The product of this gene belongs to the peptidase C56 family of proteins. It acts as a positive regulator of androgen receptor-dependent transcription. It may also function as a redox-sensitive chaperone, as a sensor for oxidative stress, and it apparently protects neurons against oxidative stress and cell death. Defects in this gene are the cause of autosomal recessive early-onset Parkinson disease 7. Two transcript variants encoding the same protein have been identified for this gene. [provided by RefSeq, Jul 2008],disease:Defects in PARK7 are the cause of autosomal recessive early-onset Parkinson disease 7 (PARK7) [MIM:606324, 168600]. Parkinson disease (PD) is a complex, multifactorial disorder that typically manifests after the age of 50 years, although early-onset cases (before 50 years) are known. PD generally arises as a sporadic condition but is occasionally inherited as a simple mendelian trait. Although sporadic and familial PD are very similar, inherited forms of the disease usually begin at earlier ages and are associated with atypical clinical features. PD is characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. PARK7 is characterized by onset before 40 years, slow progression and initial good response to levodopa.,disease:Defects in PARK7 influences susceptibility to amyotrophic lateral sclerosis-parkinsonism/dementia complex type 2 [MIM:105500]; also called amyotrophic lateral sclerosis-parkinsonism/dementia complex of Guam or Guam disease. Amyotrophic lateral sclerosis-parkinsonism/dementia complex type 2 is a neurodengenerative disorder with unusually high incidence among the Chamorro people of the Western Pacific Islands of Guam. Both amyotrophic lateral sclerosis and parkinsonism-dementia are chronic, progressive, and uniformly fatal disorders in this population. Both diseases are known to occur in the same kindred, the same sibship, and even the same individual.,function:Acts as a positive regulator of androgen receptor-dependent transcription. May function as a redox-sensitive chaperone and as a sensor for oxidative stress. Prevents aggregation of SNCA. Protects neurons against oxidative stress and cell death. Plays a role in fertilization. Has no proteolytic activity. Has cell-growth promoting activity and transforming activity.,induction:By ultraviolet irradiation.,miscellaneous:Cys-106 is easily oxidized to sulfinic acid.,online information:The Singapore human mutation and polymorphism database,PTM:Sumoylated on Lys-130 by PIAS2 or PIAS4; which is enhanced after ultraviolet irradiation and essential for cell-growth promoting activity and transforming activity.,similarity:Belongs to the peptidase C56 family.,subcellular location:Associated with mitochondria in some cells, particularly after oxidative stress. Detected in tau inclusions in brains from neurodegenerative disease patients.,subunit:Homodimer. Binds EFCAB6/DJBP and PIAS2. Part of a ternary complex containing PARK7, EFCAB6/DJBP and AR.,tissue specificity:Highly expressed in pancreas, kidney, skeletal muscle, liver, testis and heart. Detected at slightly lower levels in placenta and brain. Detected in astrocytes, Sertoli cells, spermatogonia, spermatids and spermatozoa.,

 

研究领域

Parkinson's disease;

PARK7;PARK7;Rabbit;Polyclonal;Antibody;一抗

公司简介

武汉恩玑生命科技有限公司(EnkiLife)是一家深耕生命科学,专注细胞生物学和免疫学科研试剂的研发、生产与销售的生物技术企业,在全球100多个国家和地区开展业务,致力于为科研工作者提供高质量的产品和卓越的客户服务,推动生命科学的发展。 EnkiLife的产品线涵盖细胞系、原代细胞、细胞培养基、血清、细胞检测试剂盒、重组靶点蛋白、细胞因子、重组抗体、ELISA试剂盒、生化试剂盒等,并提供技术服务与定制开发,覆盖了生命科学研究的各大关键领域,包括细胞生物学、癌症、免疫学、神经科学、心血管疾病、干细胞、表观遗传学、内分泌、蛋白质组学、代谢组学等,全方位满足您的实验需求,让您享受科研的乐趣! 公司现已建立四大技术平台: EnCyto?细胞培养及检测平台:拥有细胞系库(500+)、原代细胞库(500+)、基础培养基和完全培养基(1200+) EnkiPro?重组蛋白平台:现货产品2000+,可提供定制化表达服务 EnAb?重组抗体平台:重组兔单抗(3000+),可提供定制化和标记服务 EnKits?试剂盒开发平台:可提供优质的ELISA试剂盒、配套试剂、抗体对、生化试剂盒等相关产品 EnkiLife在生产管理方面引入ISO9001质量管理体系和信息化、自动化的管理工具,拥有高效稳定的交付能力,与全球知名品牌建立了紧密的合作。 EnkiLife始终坚持以技术创新为驱动,以匠心铸就品质,以品质服务客户。 我们期待与更多的全球科研工作者和企业携手合作,共同推动生命科学领域的进步与发展。

成立日期 (2年)
注册资本 271万人民币
员工人数 10-50人
年营业额 ¥ 100万-300万
经营模式 工厂,试剂,定制,服务
主营行业 生化试剂,抗体,细胞培养,癌症研究,细胞生物学

PARK7兔多抗相关厂家报价

内容声明
拨打电话 立即询价